chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report received from a patient concerned a 61 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: high blood pressure, GERD (gastroesophageal reflux disease), and augmentin allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 08-MAY-2021 10:00 for covid-19 prophylaxis. The batch number was not reported and has been requested. Age at time of vaccination 60 years old. Concomitant medications included lisinopril dihydrate for drug used for unknown indication. On 03-AUG-2022 20:00, the patient experienced severe and persistent bitter/metallic taste in mouth, nerve hypersensitivity (unusually sensitive skin), and joint pain. On an unspecified date, the patient experienced covid-19. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from severe and persistent bitter/metallic taste in mouth, nerve hypersensitivity (unusually sensitive skin), and joint pain, and the outcome of covid-19 was not reported. This report was non-serious.
toes felt like they were on fire; swollen right gland in throat after taking the first dose; aching after taking the first dose in the right arm; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (toes felt like they were on fire), LYMPHADENOPATHY (swollen right gland in throat after taking the first dose) and VACCINATION SITE PAIN (aching after taking the first dose in the right arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     The patient's past medical history included Anaphylaxis. Concomitant products included LANSOPRAZOLE (PREVACID) and SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced BURNING SENSATION (toes felt like they were on fire), LYMPHADENOPATHY (swollen right gland in throat after taking the first dose) and VACCINATION SITE PAIN (aching after taking the first dose in the right arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, BURNING SENSATION (toes felt like they were on fire), LYMPHADENOPATHY (swollen right gland in throat after taking the first dose) and VACCINATION SITE PAIN (aching after taking the first dose in the right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
POUNDING HEADACHES; NAUSEA; FEVER; BODY ACHES; CHILLS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 05-APR-2021, the subject experienced body aches. On 05-APR-2021, the subject experienced chills. On 05-APR-2021, the subject experienced pounding headaches. On 05-APR-2021, the subject experienced nausea. On 05-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pounding headaches, nausea, fever, chills, and body aches. This report was non-serious.
Flu-like symptoms: Achiness (whole body), Chills -  Time course:  Symptoms appeared 12 hours after vaccine administration.  Symptoms started diminishing 24 hours after onset (36 hours post-vaccination).  Symptoms totally gone 48 hours after vaccination.
Less than 10 minutes post vaccination-nausea, lightheaded, sweaty, fainted
Client had appointment with a date that appeared (looked like) to be 4/24/2021.  Administration personnel cleared the Client to receive the dose.  The vaccinator did not follow policy and get the clinical director to verify the second dose.  The vaccinator did not wait for the admin personnel to look up the patient in the system and the vaccine was given.  The administrator at the station recognized the error based on the date and the Client card was looked again.  The Client's card actually states 4/29/2021 however as the 9 was not closed off and crossing through the lines on the card, the Vaccinator as well as the Client himself thought this represented a 4.
Had flu-like symptoms for 24 hours. Very tires, total body aches, appetite loss.  Constant headache. Took Motrin as needed, and slept in naps. Took liquids. Temp 99 degrees.
Heart pounding; This is a spontaneous report from a contactable consumer (patient). A 54-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ER8732), via an unspecified route of administration in left arm on 25Mar2021 at 16:30 (at the age of 54-year-old) as dose 1, single for covid-19 immunisation in clinic. Medical history included left bundle branch block from 2017 and ongoing (She was diagnosed in either 2017 or 2018. She clarifies that she was diagnosed in 2017), acid reflux from an unknown date and unknown if ongoing, heart Condition from 2018 to an unknown date. Concomitant medications included omeprazole taken for acid reflux taking for about three and a half years and ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. It was reported that she was called about the first dose of the Pfizer COVID vaccine. She has been tried to call this number. She has also been trying to call the place that she received the first dose of the COVID vaccine and has not gotten a return phone call. She has been on hold for forever. She received her first dose of the covid vaccine on 25Mar2021. That same night, her heart was racing for four hours, and pumping very hard. She does not know if she should get the second dose of the covid vaccine. She was supposed to get it on 15Apr2021. She was worried that her heart may do this again because it was pretty severe. She was asking if she does not get the second dose of the COVID vaccine on 15Apr2021, because she needs to wait, how was that going to effect her. She was asked does it cancel it out or will she have to start over. She does not have a primary care physician. She states she should have gone to the doctor. Her heart was racing for four hours and pumping very hard. She received the first dose of the covid vaccine about 4:30PM. Her heart started pumping about 10:00PM. Her heart started pumping really hard about 10:30PM, it was beating really hard. She guesses that it was a little after 2:00AM that her heart started to go back to normal. She was terrified if it was part of that or what it could be. "She was diagnosed with a heart condition in 2018. She only has to take a medication for acid reflux. She does not have to take anything else; she was healthy. The outcome of the event was resolved on 26Mar2021.  No follow-up attempts are possible. No further information is expected.  Follow-up (02Apr2021): This follow-up contains no new medically significant information.
Very sore and tight left arm, same arm for injection, with a small lump or knot. Lump/knot is near back/shoulder and armpit. Pain radiates from spot and is painful to touch.
Lightheaded for 48 hours.  Headache, sore arm, sore neck for two weeks.  Dizziness and brain fog for 2 1/2 weeks.
Patient noticed indurated erythema, swelling, warmth, and pain at injection site on left arm.  Patient to be treated with antibiotics for cellulitis.
Aching, swelling, redness at inj. site, starting approximately 24 hours after vaccination. Returned to normal after approximately 3 more days.
Both hands swelled up; Hives; Lip swelled; Tongue swelled up a little; Couldn't talk; Muscle pain and aches, ached all over; Didn't feel so good; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received bnt162b2 (PFIZER BIONTECH COVID-19 vaccine, Formulation: Solution for injection, Lot number: EP6955, Expiration date: unknown) via an unspecified route of administration, administered in arm left on 20Mar2021 (at the age of 67-year-old) as DOSE 1, SINGLE for COVID-19 immunization. Medical history included COVID (patient dad died of COVID and other family members had covid) from an unknown date and unknown if ongoing. There were no concomitant medications reported. The patient had no prior vaccinations within 4 weeks. The patient did not administer any additional vaccines on same date of the pfizer suspect. Historical vaccine included flu vaccine which led to arm ached and muscle ached from an unspecified date in Sep2020 (at the age of 66-year-old). On 22Mar2021, the patient didn't feel so good. On the same day at 01:00, the patient experienced muscle pain and aches, ached all over. On 23Mar2021, she was there alone with nobody to talk to during the day. She went to facetime one of her sister's and she could hardly talk. On the same day at 10:00 in the morning, the patient's lip swelled and tongue swelled up a little. On 24Mar2021, around 8 to 9 o'clock, in the morning, the patient both hands swelled up and hives. Caller stated that on monday, she didn't feel so good, but she said that was expected. She reported on tuesday, her lip swelled up and her tongue swelled up a little. She couldn't talk in the afternoon, for some reason, her voice, she didn't know. By 5 pm, her voice got better. Yesterday, her hand swelled up, later clarified as both her hands swelled up. She also had hives. Caller asked, OK, she wanted to make sure she could get the second shot, should she be worried about getting the second shot. The patient underwent lab tests and procedures which included SARS-CoV-2 test: negative (she was pretty sure she had covid, but the test came back negative, she had all the symptoms) on an unspecified date in Dec2020. The patient did not visited emergency room and physician office for the adverse events. The patient was treated with benadryl (Lot: 1805142 & Expiration: Aug2022) last night as a therapeutic measure of hives. On 23Mar2021, the patient recovered from didn't feel so good, muscle pain and aches, ached all over, lip swelled, tongue swelled up a little and couldn't talk. The outcome of the events both hands swelled up and hives was recovering.  No follow-up attempts are possible. No further information is expected.
Narrative: Fully vaccinated, COVID positive on admission for weakness, lethargy, and confusion. Patient was treated for sepsis and COVID.
3 days after first primary immunization, patient developed urticaria from lower abdomen to lower extremeties. No accompanying fever, excessive crying, pruiritus.
Vaccine administered on 4/08/2022 expired on 04/06/2022
Proquad and Varivax vaccines were given to same patient at same visit by accident. Proquad lot# X007085 Exp. 09/04/2024 Merck and Co. Inc NDC# 00006-417-00 Varivax Lot# X006980 Exp. 03/07/2025 Merck and Co., Inc. NCD 00006-487-00  Medication administered to or used by the patient Yes  Outcome Pt is doing fine and did not have side effects.  Reporter's recommendations All new and seasoned nurses will have another nurse verify the vaccines they are about to give by another nurse before administering. All nursing staff have been educated about making sure you are giving the correct vaccine and STOP and double check.   Severity Error reached patient; no patient harm
Patient contracted COVID after being fully vaccinated.  No Booster. fatigue, runny nose, congestion, headache, fever, cough.
Had a reaction on left thigh, post vax, on 10/30/00, 2" X 3" area of erythema, slight induration and almost welting.
Rash on her arm - bellow the injection site/Rash spread a little bit; Arm feels stiff,hard; Arm feels lumpy; Arm feels warm to the touch; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Arm feels stiff,hard), VACCINATION SITE MASS (Arm feels lumpy), VACCINATION SITE WARMTH (Arm feels warm to the touch) and RASH (Rash on her arm - bellow the injection site/Rash spread a little bit) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to vaccine (Patient reported that she had allergic reaction to a shingles shot ) and Allergy to chemicals NOS (Patient reported that she has allergic to preservatives such as thimerosal and parabens.).   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Arm feels stiff,hard), VACCINATION SITE MASS (Arm feels lumpy) and VACCINATION SITE WARMTH (Arm feels warm to the touch). On 29-Mar-2021, the patient experienced RASH (Rash on her arm - bellow the injection site/Rash spread a little bit). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of 1 dosage form and IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at a dose of 1 dosage form. At the time of the report, MUSCULOSKELETAL STIFFNESS (Arm feels stiff,hard), VACCINATION SITE MASS (Arm feels lumpy), VACCINATION SITE WARMTH (Arm feels warm to the touch) and RASH (Rash on her arm - bellow the injection site/Rash spread a little bit) was resolving.            No Concomitant medication provided  by the reporter.  Treatment medications includes application of ice on the am.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Event outcome was updated.
Information has been received from a nurse concerning a 4 year old child who, over the past month, in approximately July 2006, was vaccinated with MMR. Concomitant therapy included PEDIARIX. Unspecified medical attention was sought. About 2 days after injection, in approximately July 2006, the patient experienced cellulitis at the injection site. About five days after injection, in approximately July 2006, the patient recovered. The reporting physician also reported the experiences of 4 other patients with MMR (WAES # 0609USA00641, 0609USA00642, 0607USA00643, 0609USA05076). Additional information has been requested.
Arm is sore; did not feel to hot and face was hot; Slight fever; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Arm is sore), FLUSHING (did not feel to hot and face was hot) and PYREXIA (Slight fever) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety (Anxiety under control with medications.).   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm is sore), FLUSHING (did not feel to hot and face was hot) and PYREXIA (Slight fever). At the time of the report, PAIN IN EXTREMITY (Arm is sore) and PYREXIA (Slight fever) outcome was unknown and FLUSHING (did not feel to hot and face was hot) had resolved. Not Provided          Concomitant medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 06-Feb-2021: TCR was attached. The patient was received treatment medication and second dose of vaccine was received.
Employer compelled me to take a third vaccine (took both shots in July, but doses were spaced lesser than 4 weeks) at the risk of losing my employment (doctoral student). Pharmacist strongly advised against it, but I persisted (to not lose my job). The first night (T+ 6-16 hours) I laid awake all night with severe myalgias, a 101 fever, body chills, and an intermittent headache. between T 16-48 I continued to experience moderate to severe myalgia and headache grew increasingly painful (6/10) but fever began to attenuate by +36 hours. Between T+ 48-72 hours I could barely get out of bed, but other symptoms slowly improved. Decided not to go to hospital at the suggestion of my PCP.
1)Rash-reddened blotches on chest & body beginning 1/11/01 2) Reddened area (size of quarter) oblong, raised and warm to touch on left leg. small area of same nature on right leg began 01/10/01
went to go lay back down/fainted; went to go lay back down; felt nauseous; Went to lay in bed and was sweating a lot; Before I fainted I had taken some ibuprofen for the headache; This is a spontaneous report from a contactable consumer patient(herself) reported. A 35-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EM9810, Expiration date: unknown), via an unspecified route of administration in arm left on 10Apr2021 at 12:00 PM as single dose for covid-19 immunization. The patient historical vaccine included first dose BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number: EM9810, Expiration date: unknown), via an unspecified route of administration in left arm on 20Mar2021 at12:00 PM as single dose Covid-19 immunization. Patient medical history included fatty liver disease. Patient had known to allergies sulfa medication. Patient concomitant medication in two weeks included escitalopram oxalate (LEXAPRO), allergy medicine, allergy nasal spray. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the post vaccination. Patient experienced about 16 hours after the vaccine went to go lay back down, felt nauseous and fainted, got back up and fainted again. Went to lay in bed and was sweating a lot 11Apr2021 at 05:15 AM. Before fainted, patient had taken some ibuprofen for the headache. Patient not received treatment for the events. The outcome of the event was unknown.
I had fits of uncontrollable sneezing on July 20th. I just happened to take a test on the 21st and it was positive. I called my doctor and she gave me PAXLOVID due to my asthma. I finished the PAXLOVID on July 25th. During the whole time I only had sneezing and fatigue. I continued to work from home. I tested negative on 26th so returned to work.
Pt vaccinated with Influenza developed local rxn: swelling, warmth, redness began 15 days after injection. Knot and redness lasted 4 days. Also, systemic rxn: cough, fever (not taken), sore throat, rhinitis began 15 days after injection.
Received vaccine at 2:10pm, 8:00pm headache, 10:00pm body aches and chills started (took 1000mg of Tylenol), 11:00pm- 6:00am severe body chills- uncontrollable shaking , 3:00am 103.9 fever with hallucinations  (took 1000mg of tylenol), 6:00am fever broke, followed by all day exhaustion and sore arm.
No adverse event; 47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7642B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 28-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date.).    No relevant concomitant medications were reported. Patient was over 18 years of age.  Staff gave patients vaccines past the use date of 18 Jun 2023. On 28 Jun 2023, 9 doses were administered at administration site 1.  No treatment medications were reported.   This case is for the 6th patient out of 47 reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-732752 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2023: Live significant follow up received: Vaccine administration date was updated; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-732752:Master case (Patient 01)
Still have lingering bone/joint pains and muscle aches down my legs from my hips flaring on and off almost a month later. Hands too.
2hr p/vax noticed little redness & the site;16OCT became inc red w/swelling, T101.8;17OCt T100.0;18OCT T99.9 then nl 19OCT;redness & swelling dec as of 21OCT97;
infanrix given  instead of Boostrix; Adult received Infanrix; This case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 26-year-old male patient who received DTPa (Infanrix) (batch number 7EC55, expiry date 29th April 2023) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 10th February 2023, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 10th February 2023, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt date: 13-Feb-2023. Reporter's Comment: Reporter stated that they inadvertently administered Infanrix to an adult patient instead of Boostrix. Nurse inquired what to look for. The reporter did not consent to follow-up. Additional Supportive Information: An adult patient received Infanrix instead of Boostrix inadvertently, which led to wrong vaccine administered and inappropriate age at vaccine administration.
Within 2 hours of getting Pneumovax vaccine R arm began to hurt, became very painful, 9/10, swollen, red areas 5-6" long. Started 2/9/09 PM and resolved by 2/11/09 AM. Pt took ibuprofen and Benadryl and applied ice at site.
Beginning 9.5 days after my injection, for three days, I experienced a variety of skin ailments at different times and places on my body, and various intensities from mild to severe.  These included  a blotchy red face and redness, swelling and itching : of the  inner left arm , all of my extremities, in particular areas such as wrists and ankles, around one shoulder.  The itching around my right shoulder was sudden and intense, requiring two Benedryl pills to calm enough that I could sleep.  On the third morning, my right wrist itched  and swelled but responded to an OTC cream.  The second day my legs felt sore to the touch.  No symptoms occurred on my core.